Prollenium - Medical Technologies Inc
  • COMPANY
  • PRODUCTS
  • R & D
  • BUSINESS DEVELOPMENT
  • NEWS
  • CONTACT
View Menu
Close Menu
  • Company
  • Products
  • R&D
  • Business Development
  • News
  • Contact


  • Aug 2012: Congratulations to IvetaVinklerova from Boston Medical Group, Prollenium's distributors in the UK, for becoming a finalist for Sales Rep of the Year in the Aesthetic Awards 2012-2013. Revanesse is also in the running for the Injectable Product of the Year award so well done to the whole team at Boston Medical Group.
  • July 2012: Asian Pacific distributors Medicell represent Revanesse at IMCAS SHANGAI.
  • July 2012: German distributors HaBaMedMedizinprodukte represent Revanesse at the Dermatology and Venereology congress in Munich.
  • July 2012: South African distributors Morning Star Surgical represent Revanesse at the hugely successful Cosmedic 2012 show in Cape Town, South Africa.
  • May 2012: NEW DISTRIBUTION in Russia - Best Estetika, gain approvals for the Revanesse line to sell in the Russian territory.
  • May 2012: Prollenium attends RADLA – Annual Meeting of Latin American DermatologySao Paulo - Brazil
  • Apr 2012: UK distributors Boston Medical Group represent Revanesse at the Cosmetic News Expo 2012, London, UK.
  • Apr 2012: Prollenium attends the 3rd SICAAAMS 2012 – Geneva - Swiss.
  • Mar 2012: BD Aesthetic ramp-up sales to take the Revanesse line to one of the top 5 fillers sold in Poland.
  • Mar 2012: Prollenium is a Silver Sponsor at AMWC 2012 – Monte Carlo – Monaco.
  • Feb 2012: Prollenium attends the 8th IACD World Congress of Cosmetic Dermatology – Cancun Mexico.
  • Jan 2012: Prollenium is a Gold Sponsor at IMCAS PARIS.
  • June 2011: New PRODUCT –Lyracaine Topical Anaesthetic (5% Lidocaine) introduced. No occlusion formula has significant advantage over competition.
  • May 2011: NEW PRODUCT, Microfill Blunt-Tip Cannulas available in 23G (38mm) and 26G (38mm) for better control of Revanesse injections.
  • Mar 2011: Prollenium is a Silver Sponsor at AMWC 2011- Monte Carlo – Monaco.
  • Feb 2011: NEW DISTRIBUTION in Israel - Lapidot Group brings the Revanesse line to the market in Israel.
  • Feb 2011: GRAND OPENING of our new facility.Aurora, Ontario, Canada.
  • Jan 2011: Prollenium is a Gold Sponsor at IMCAS PARIS conference.
  • 08/01/2010: Prollenium Initiates New Partnership With Canderm GP.
  • 06/02/2010: Prollenium Medical Technologies Inc. Ranked in PROFIT Magazine as one of Canada's fastest growing companies.
  • 05/21/2010: Revanesse Dermal Fillers Expands to Brazilian Market.
  • 06/29/2009: Prollenium Ranked in PROFIT Magazine as one of the Nation’s Fastest Growing Companies.
  • 03/19/2009: 03/19/2009 Prollenium Medical Technologies Bucks Market Trends & Increases Expenditures.
  • 02/12/2009: Prollenium Signs License and Development Deal with the University of Toronto.
  • 01/09/2009: Prollenium Expands Marketing Strategies for 2009
  • Prollenium Ranked in PROFIT Magazine Amongst the Nation’s Fastest Growing Companies
  • Prollenium Medical Technologies Announces Partnership Agreement with Ajanta Pharma to Market Revanesse® in India
  • Prollenium Medical Technologies Inc Ranked Among Canada’s Top 50 Emerging Growth Companies
  • Nov 2006: Introducing Revanesse®, the Newest Generation of Dermal Fillers
  • Nov 2006: Injectibles to Soon Offer Complete Facial Rejuvenation
  • Dec 2005: Revanesse® Family of Dermal Fillers Receives Health Canada Approval
© 2012 Prollenium Medical Technologies Inc
English   French   Spanish   German